RSH Index Page
RSH > Documents > RSH Data Docs > 1.2 > 1.2.6 > 1.2.6.3 Natural Radiation and Radioactivity - Radon
References

"Low Level
Radiation Health Effects: Compiling  the Data"

Revision 1
March 19, 1998
by Radiation, Science, and Health, Inc.
,
Edited by J. Muckerheide

1.2.6
Natural Radiation and Radioactivity

1.2.6.3
Natural Radiation and Radioactivity - Radon


Professor R.C. von Borstel, Dept. of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada, in a review of "Health Effects of Low-level Radiation", by Sohei Kondo, states (1995) that: "In another analysis that Kondo made on data of [many] populations exposed to radon, his findings are in direct contrast to the estimates of the US EPA... (T)he individuals exposed to radon have beneficial effects with respect to cancer mortality. Kondo's analyses are extensive and profound."

Drs. Gary M. Sandquist, Jay F. Kunze, and Vern C. Rogers and their collegues in Utah show (1997) inconsistencies with the LNT: in comparing EPA lung cancer projections with actual cancer incidence data published by the American Cancer Society, using the US EPA study of radon potential, the EPA Region with the highest background radon levels (CO, MT, ND, SD, UT, WY) exhibits a mean lung cancer incidence rate of 4.4x10-4, which is only 14% of the rate from the LNT model. On the other hand, the EPA Region with the lowest background radon (ID OR WA) exhibits a mean lung cancer rate of 7.3x10-4, which is 390% of the LNT model predicted rate. It is significant that not only are the LNT-projected health effects at considerable variance with actual health data, but that the LNT projections for all EPA Regions consistently scale inversely with actual observations.

Dr. W. Schuttmann formerly of the Faculty of Industrial Hygene, Department of Health, Berlin Germany and Professor Dr. K. Becker of the German Standards Institute report (1998) that: female lung cancer rates in high radon uranium mining areas of Southern Saxony are substantially lower than the average of East Germany. Thus, the data from various countries showing biopositive effects of increased radon levels can be confirmed in an area which has been closely associated with the history of radiation health effects. The comprehensive GDR cancer register shows no increased female lung cancer in this region. In fact, one of the high radon mining districts was among the lowest of the country. Nevertheless, extreme remediation efforts have a radon-related cost of about $US 2,000 million. This area is another ideal location to test the 'official' assumptions about radiation health hazards in general and indoor radon hazards in particular. The actual risk, comparing the country average and actual female lung cancers in the high-radon areas between 1983 and 1987, show exactly the contrary.

     


RSH > Documents > RSH Data Docs > 1.2 > 1.2.6 > 1.2.6.3 Natural Radiation and Radioactivity - Radon
 

For more information please contact the RSH President Jim Muckerheide

For website problems please contact the Webmaster
 

Google Scholar

06/13/06